Beijing Wantai Biological Pharmacy Enterprise Co Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 0.99x

Beijing Wantai Biological Pharmacy Enterprise Co Ltd cash flow reinvestment rate. Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a Cash Flow Reinvestment Rate of 0.99x as of September 2025, reinvesting CN¥125.45 Million (capex CN¥125.45 Million ) from operating cash flow of CN¥127.35 Million. See financial flexibility index of Beijing Wantai Biological Pharmacy Enter to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.99x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥125.45 Million
Capex + Investments

Operating Cash Flow

CN¥127.35 Million
CNY

Capital Expenditures

CN¥125.45 Million
CNY

Cash Flow Reinvestment Rate of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

Cash flow reinvestment rate of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. Historical reinvestment intensity for Beijing Wantai Biological Pharmacy Enterprise Co Ltd across 13 annual periods. Explore 603392 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Cash Flow Reinvestment Rate by Year (2013–2025)

Beijing Wantai Biological Pharmacy Enterprise Co Ltd cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Beijing Wantai Biological Pharmacy Enterprise Co Ltd. For the full cash flow conversion analysis, see Beijing Wantai Biological Pharmacy Enter operating cash flow efficiency.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 10.84x CN¥972.52 Million CN¥89.75 Million CN¥805.16 Million ▲ +150.0%
2024 4.33x CN¥1.54 Billion CN¥355.08 Million CN¥887.35 Million ▲ +116.3%
2023 2.00x CN¥3.21 Billion CN¥1.60 Billion CN¥1.16 Billion ▲ +135.3%
2022 0.85x CN¥3.52 Billion CN¥4.13 Billion CN¥929.91 Million ▲ +34.8%
2021 0.63x CN¥1.06 Billion CN¥1.68 Billion CN¥1.05 Billion ▼ -38.0%
2020 1.02x CN¥476.96 Million CN¥468.21 Million CN¥390.44 Million ▲ +32.1%
2019 0.77x CN¥210.20 Million CN¥272.68 Million CN¥162.00 Million ▼ -34.8%
2018 1.18x CN¥246.39 Million CN¥208.31 Million CN¥246.06 Million ▼ -44.2%
2017 2.12x CN¥311.73 Million CN¥146.97 Million CN¥214.65 Million ▼ -16.6%
2016 2.54x CN¥329.00 Million CN¥129.40 Million CN¥131.26 Million ▲ +395.4%
2015 0.51x CN¥77.92 Million CN¥151.84 Million CN¥77.92 Million ▼ -12.2%
2014 0.58x CN¥77.43 Million CN¥132.43 Million CN¥77.43 Million ▼ -30.3%
2013 0.84x CN¥82.12 Million CN¥97.83 Million CN¥82.12 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow